Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.


Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013



All Upcoming Events
1 2 3 Next 
2017 American Society for Cytotechnology Annual Conference28 Apr 2017
World Drug Safety Americas 20173 May 2017
The Society of Environmental Toxicology and Chemistry (SETAC) Europe 27th Annual Meeting7 May 2017
Pharmaceutical Freeze Drying Technology8 May 2017
ISBER Annual Meeting & Exhibits 20179 May 2017
The American Association of Immunologists 201712 May 2017
Orphan Drugs and Rare Diseases Europe 201715 May 2017
LABVOLUTION with Life Sciences Event BIOTECHNICA 201716 May 2017
11th Pharmaceutical Logistics18 May 2017
19th International Conference on Pesticide Chemistry (ICPC 2017)21 May 2017
Pain Therapeutics 201722 May 2017
Highly Potent Active Pharmaceutical Ingredients 201722 May 2017
Pharmaceutical Traceability22 May 2017
World Biosimilar Congress USA 201723 May 2017
Americas Antibody Congress 201723 May 2017
Cell Culture World Congress USA24 May 2017
65th ASMS Conference4 Jun 2017
Pre-Filled Syringes West Coast 20175 Jun 2017
The High Potent Medicines Conference6 Jun 2017
2nd Annual Bioprocessing of Advanced Cellular Therapies Congress8 Jun 2017
Pharmaceutical Microbiology USA8 Jun 2017
12th Annual ADMET 201712 Jun 2017
4th Annual Immunogenicity12 Jun 2017
In Vitro Diagnostics 201714 Jun 2017
Biobanking 201714 Jun 2017
2nd International Conference on Marine Drugs & Natural Products15 Jun 2017
HPLC 201718 Jun 2017
3rd International Conference and Expo on Biopharmaceutics and Biologic Drugs19 Jun 2017
Association for Environmental Studies and Sciences (AESS) 2017 Conference21 Jun 2017
International Conference on Environmental Chemistry and Engineering24 Jun 2017

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement